Table 2.
Treatment and Outcome of Patients with Mesenteric Venous Thrombosis: Data from Reported Observational Studies.
| Author (year) | N | FU (years.) | Treatment (%) | Survival (%) | |||||
|---|---|---|---|---|---|---|---|---|---|
| Surgery | Infarction | Anticoagulation | Bleed | Recurrenced | Short-term | Overall | |||
| Abdu (1986) | 372 | NA | NA | NA | NA | NA | NA | NA | NA |
| Harward (1989) | 16 | 2.75 | 31 | 25 | 100 | NA | NA | 81 | NA |
| Rhee (1994) | 72 | 1.6 | 64 | NA | 62 | NA | 36 (25) | ||
| Condat (2000)a | 33 | 2.5 | 6 | 12 | 93 | 6 | 13 (0) | 100 | 97 |
| Morasch (2001) | 31 | 4.75 | 32 | NA | 72 | NA | NA | 77 | 68 |
| Brunaud (2001)b | 26 | 4.25 | 50 | NA | 50 | NA | NA | 81 | 77 |
| Kumar (2003)a | 69 | NA | 44 | NA | 91 | 1 | 6 | NA | NA |
| Zhang (2004)b | 41 | 2.75 | NA | NA | NA | NA | 3 (0) | 78 | 73 |
| Grisham (2005) | 23 | NA | 17 | NA | 100 | NA | NA | NA | 93 |
| Amarapurkar (2007) | 28 | 4.2 | 36 | 29 | 75 | 13 | 22 (22) | 84 | 81 |
| Amitrano (2007)c | 121 | 3.5 | 26 | 28 | NA | 15 | 11 | 95 | 90 |
| Acosta (2008) | 51 | NA | 25 | NA | NA | NA | NA | 80 | 67 |
| Abu-Daff (2009) | 31 | 5 | 77 | NA | NA | NA | NA | 87 | 68 |
| Alvi (2009) | 20 | 23 | 40 | NA | 85 | NA | NA | 80 | NA |
| Dentali (2009) | 77 | 3 | NA | NA | 46 | NA | 6 | 100 | 94 |
| Cendese (2009) | 9 | 2.25 | 55 | 5 | 100 | NA | NA | 100 | 89 |
| Thatipelli (2010) | 76 | 2.25 | NA | NA | 54 | 18 | 40 | NA | 75 |
| Plessier (2010)a | 55 | 1 | NA | 2 | 95 | 8 | NA | 100 | 98 |
a
Portal and mesenteric thrombosis included.
b
Mesenteric venous thrombosis with symptoms of <4 weeks duration.
c
Splanchnic venous thrombosis without cancer or cirrhosis.
d
Figures in parentheses represent proportion of recurrent patients with recurrence in the mesenteric vein.